Investigation of cardiovascular protective effect of Shenmai injection by network pharmacology and pharmacological evaluation

BACKGROUND: Shenmai injection (SMI) has been used in the treatment of cardiovascular disease (CVD), such as heart failure, myocardial ischemia and coronary heart disease. It has been found to have efficacy on doxorubicin (DOX)-induced cardiomyopathy. The aims of this study were to explore the underl...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lin, Yang, Dongli, Li, Jinghao, Niu, Lu, Chen, Ye, Zhao, Xin, Oduro, Patrick Kwabena, Wei, Chun, Xu, Zongpei, Wang, Qilong, Li, Yuhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158159/
https://www.ncbi.nlm.nih.gov/pubmed/32293408
http://dx.doi.org/10.1186/s12906-020-02905-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158159/
https://www.ncbi.nlm.nih.gov/pubmed/32293408
http://dx.doi.org/10.1186/s12906-020-02905-8

Ejemplares similares